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Old and new global challenges in infectious
diseases
P. Piot
London School of Hygiene & Tropical Medicine,
London, United Kingdom
Unprecedented progress in the prevention and treatment of
infectious diseases has been made worldwide, resulting in a major
decrease in child and overall mortality and contributing to an epi-
demiological transition to chronic diseases. However, there is still a
hugeunﬁnished agenda: 1)Overall, the poor remaindisproportion-
ally affected by infectious diseases and their consequences; 2) The
polio endgame turns out more complex than anticipated; 3). The
end of HIV/Aids, TB and malaria is not in sight; 4) Immunisation
rates are highly variable, and vaccine refusal is growing in many
countries; 5) The historic gap between prevention and treatment
continues. In addition, new challenges are emerging: 1) Antimicro-
bial, antiviral and insecticide resistance are rapidly increasing in a
wide rangeofpathogens, includingentericbacteria,M.tuberculosis,
Plasmodium sp, HIV, and anopheles; 2) Co-morbidity with chronic
diseases is rising, such as treated chronic HIV infection and car-
diovascular and metabolic disorders, or TB and diabetes; 3) New
pathogens will continue to emerge; 4) Urbanisation and migra-
tion; 5) Climate change, environmental degradation and natural
disasters. At the same time numerous opportunities are arising to
respond more effectively to infectious diseases: 1) New drugs and
vaccines, such as to cure hepatitis C; 2) Simple point of care diag-
nostics; 3) Genomics and microbiomics; 4) More effective disease
surveillance and early warning; 5) New approaches to disease pre-
vention, suchasusingmobile technologyandbehavioureconomics.
intensifying progress in infectious diseases will require continuing
global and national leadership and funding, as well as to ensure
much greater synergies between population health, prevention,
treatment and care, and development efforts.
http://dx.doi.org/10.1016/j.ijid.2014.03.490
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Healthcare personnel (HCP) attire in acute-care,
non-surgical settings
G. Bearman
Virginia Commonwealth University, Richmond, VA,
USA
Healthcare personnel (HCP) attire is an aspect of the med-
ical profession steeped in culture and tradition. The role of
attire in cross-transmission remains poorly established and until
more deﬁnitive information exists, priority should be placed
on evidence-based measures to prevent hospital acquired infec-
tions (HAI). This presentation will review the medical literature
regarding a) perceptions of HCP attire from the perspective of
patient andproviders b) evidence for contaminationof attire and its
potential contribution to cross-transmission. Although the optimal
choice of HCP attire for inpatient care remains undeﬁned, recom-
mendations on the use of white coats, neck ties, footwear, the
bare-below-the-elbows strategy, and laundering will be covered.
http://dx.doi.org/10.1016/j.ijid.2014.03.491
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Horizontal versus vertical infection prevention
strategies
M.P. Stevens
Virginia Commonwealth University, Richmond, VA,
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Strategies to decrease healthcare-associated infections (HAIs)
can be classiﬁed into two different categories: horizontal and
vertical. Horizontal strategies are universally-applied, population-
based strategies that target all pathogens that are transmitted
via the same mechanism. Examples of this strategy include
hand hygiene, chlorhexidine bathing and the deployment of
care bundles. Vertical strategies target individual pathogens
that are deemed to be particularly important and involve high
resource utilization and costs. An example of a vertical infection
control strategy is universal screening for methicillin-resistant
Staphylococcus aureus (MRSA) colonization.
MRSA active detection and patient isolation has been a point
of major controversy in the ﬁeld of infection control over the last
decade. This strategy involves screening patients on admission to
healthcare facilities and isolating patients who test positive. Some
data suggested that this strategy led to decreased HAIs; however,
the majority of these studies produced low-quality evidence.
Despite this, many hospitals embraced active MRSA detection and
isolation programs and these programs were legally mandated in
nine states in theUnited States. A key concernwith the deployment
of active detection strategies is the resource costs associated with
these programs; money and time dedicated to these programs
comes at a cost to other infection control initiatives that often have
greater impact.
Models suggest that horizontal infection control approaches
will be more successful (in terms of rates of infections with major
pathogens and cost) than vertical strategies. Recently, a large,
multicenter cluster-randomized study by Huang and colleagues
showed that universal decolonization (a horizontal strategy) was
more effective at reducing MRSA-positive clinical cultures and
bloodstream infections from any pathogen when compared to
active detection and isolation. Given the ﬁnite resources avail-
able to many infection control programs, focusing on high-impact
strategies that cut across all organismswith similarmechanisms of
transmission is logical.
http://dx.doi.org/10.1016/j.ijid.2014.03.492
